Latest filing published 03 Jun 2025 for REGENXBIO Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Argeris N. Karabelas is a declared insider at 2 companies; the most frequent names are REGENXBIO Inc. and Bausch Health Companies Inc. Over a trading history stretching from 30 April 2021 to 30 May 2025, the count stands at 11 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 3 June 2025: a share grant, in REGENXBIO Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations